There is provided a new pharmaceutical product comprising Compound (A) characterized by a dosage regimen which maximizes anti-tumor activity while maintaining acceptable toxicity levels.
申请公布号
WO2013139687(A1)
申请公布日期
2013.09.26
申请号
WO2013EP55324
申请日期
2013.03.15
申请人
F. HOFFMANN-LA ROCHE AG;GLENN, KELLI;HIGGINS, BRIAN;NICHOLS, GWEN;PACKMAN, KATHRYN E.
发明人
GLENN, KELLI;HIGGINS, BRIAN;NICHOLS, GWEN;PACKMAN, KATHRYN E.